Pfizer Launches Mobile App Tracking Global Drug Resistance Rates

Pfizer has launched its mobile app and website, ATLAS, this week in an effort to help insurers, physicians, and everyday consumers track resistance rates and drug trends. The app allows users to see global resistance rates as well as pinpointed areas around the world....

Pfizer Set to Acquire Hospira

Pfizer announced in a press release that “they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 a share...